Stock indexes in the U.S. rose Monday with the rising 1.86%. Meanwhile, the added 1.23%, and the added 0.71%.

BioMarin Pharmaceutical (Nasdaq: BMRN) missed both revenue and earnings estimates in the third quarter, and yet, shares are ...

The company raised its full-year 2025 total revenue guidance to $3.15-3.2 billion from its previous outlook of $3.125-3.2 billion, while maintaining its VOXZOGO revenue forecast of $900-935 million.

Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...

BIO-key® International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM ...

BridgeBio Pharma shares surge on positive BBP-418 trial results for limb-girdle muscular dystrophy. Read more here.

BridgeBio Pharma (NASDAQ:BBIO) shares surged 15% on Monday after the company announced highly positive Phase 3 results for ...

With U.S. stock markets set to open in two hours, Avidity Biosciences Inc. (RNA) was up 43.6% in pre-market trading, and BridgeBio Pharma Inc. (BBIO) was up 10.6%.

BIO-key International, Inc. (NASDAQ:BKYI) shares soared 180% in premarket trading Monday after the biometric authentication ...

Novartis announces agreement to buy Avidity Biosciences for $12 billion. Here's why NVS is paying such a hefty premium for ...

LUND, SE / ACCESS Newswire / October 27, 2025 / BioInvent International AB ("BioInvent")(Nasdaq Stockholm:BINV)(STO:BINV) invites investors, analysts and the press to a presentation of the interim rep ...

Grupo Financiero Galicia S.A. (NASDAQ: GGAL) gained 36% to $48.15. Shares of Argentine stocks traded higher after President ...